Authors' response to a reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'. (1st February 2017) - Damian, D.L.; Martin, A.J.; Scolyer, R.A.; Chen, A.C.; Halliday, G.M.